SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-152387
Filing Date
2023-05-24
Accepted
2023-05-24 07:02:35
Documents
18
Period of Report
2023-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d493912d8k.htm   iXBRL 8-K 54042
2 EX-2.1 d493912dex21.htm EX-2.1 508937
3 EX-10.1 d493912dex101.htm EX-10.1 30492
4 EX-99.1 d493912dex991.htm EX-99.1 37398
9 GRAPHIC g493912dsp117.jpg GRAPHIC 5417
10 GRAPHIC g493912dsp117a.jpg GRAPHIC 4726
  Complete submission text file 0001193125-23-152387.txt   962472

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA apgn-20230523.xsd EX-101.SCH 3726
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apgn-20230523_def.xml EX-101.DEF 14219
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE apgn-20230523_lab.xml EX-101.LAB 23975
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apgn-20230523_pre.xml EX-101.PRE 15057
12 EXTRACTED XBRL INSTANCE DOCUMENT d493912d8k_htm.xml XML 6064
Mailing Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070
Business Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39488 | Film No.: 23950570
SIC: 2834 Pharmaceutical Preparations